http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf04056ddaef31f9000a214f5d918c05
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Caldas |
| name | Carlos Caldas |
| given-name | Carlos |
| organization-name | Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.; Cambridge Breast Unit, Addenbrooke’s Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK.; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. 1Cancer Genomics Program, Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Research Center, Cambridge, United Kingdom and European Academy of Cancer Sciences Stockholm Sweden; Cancer Research UK Cambridge Centre Cambridge UK John M.S. Bartlett, Ontario Institute for Cancer Research; Frances P. O'Malley, St Michael's Hospital; Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre and University of Toronto, Toronto; John M.S. Bartlett, Frances P. O'Malley, and Lois E. Shepherd, National Cancer Institute of Canada Clinical Trials Group; Lois E. Shepherd, Queen's University, Kingston, Canada; John M.S. Bartlett, Alison F. Munro, and David A. Cameron, University of Edinburgh, Edinburgh; Christopher C. McConkey, Janet A. Dunn,... Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre University of Cambridge Cambridge UK; Breast Cancer Programme Cancer Research UK (CRUK) Cambridge Cancer Centre Cambridge UK 5Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom. 4Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde Gandra Portugal; CINTESIS—Center for Health Technology and Services Research, Faculty of Medicine University of Porto Portugal Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK. University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom 9Cancer Research UK, Cambridge Institute and Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; 10Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation, Trust and NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom.; 11Cambridge Experimental Cancer Medicine Centre, Cambridge, United Kingdom. Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals. Cambridge Experimental Cancer Medicine Centre, Cambridge. Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, United Kingdom. Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge, Li Ka-Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.; Cambridge Breast Unit, Addenbrookes Hospital and Cambridge National Institute for Health Research Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. 1Cancer Genomics Program, Hutchison-MRC Research Centre, Departments of Pathology and Oncology, University of Cambridge, Cambridge, United Kingdom; 4Breast Cancer Genomics Group, Cancer Research UK, Cambridge Institute, Cambridge University, Cambridge, United Kingdom. 6CRUK Cambridge Institute, Cambridge, UK. 1Cancer Research UK Cambridge Centre, Cambridge, United Kingdom. Cancer Genomics Program, Department of Oncology, University of Cambridge, Hutchison/MRC Research Centre, Hills Road, Cambridge CB2 2XZ, United Kingdom; and Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1GA, United Kingdom 7Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom. Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, United Kingdom Cancer Research UK, Cambridge Institute & Department of Oncology Li Ka Shing Centre Cambridge UK; Cambridge Breast Cancer Research Unit CRUK Cambridge Cancer Centre Cambridge UK; NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre Cambridge University Hospital NHS Foundation Trust Cambridge UK for the AACR Project GENIE Consortium Cancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge, UK. 1Cancer Research UK Cambridge Research Institute; Department of Oncology and Cancer Research, UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom Cancer Research UK Cambridge Institute Li Ka Shing Centre University of Cambridge Cambridge UK Department of Biochemistry and the Hutchison/MRC Research Centre, Department of Oncology, University of Cambridge, Cambridge, U.K., Biomedical NMR and National Bio-NMR Facility, A.I. Virtanen Institute for Molecular Sciences, University of Kuopio, Finland, and School of Sport and Exercise Sciences, University of Birmingham, Birmingham, U.K. Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.; Department of Oncology, University of Cambridge, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 0QQ, UK.; Addenbrooke’s Hospital, Cambridge University Hospital NHS Foundation Trust and National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK.; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, UK.; Department of Oncology, University of Cambridge, Cambridge CB2 2XZ, UK.; Cambridge Breast Unit, Addenbrooke’s Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK.; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre, University of Cambridge Cambridge UK Breast Cancer Functional Genomics, Cancer Research UK Cambridge Institute, Department of Oncology, University of Cambridge, Li Ka-Shing Centre, Cambridge, United Kingdom. Department of Oncology, and Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. for the American Association of Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) Consortium Department of Oncology Cancer Research UK Cambridge Institute University of Cambridge UK 2Cancer Genomics Program, Department of Oncology, Hutchison/Medical Research Council Research Centre, University of Cambridge, Cambridge, United Kingdom Cancer Research UK Cambridge Institute Li Ka Shing Centre University of Cambridge Cambridge UK; Cancer Research UK Major Center ‐ Cambridge Cambridge UK; Department of Oncology University of Cambridge Cambridge UK; Department of Oncology Addenbrooke's Hospital Cambridge University Health Partners Cambridge UK 4Cancer Genomics Program, Department of Oncology, Hutchison/Medical Research Council Research Centre, University of Cambridge, Cambridge, United Kingdom Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. Cancer Research UK Cambridge Institute, Cambridge, England Cambridge University Hospitals Trust Addenbrookes Hospital Cambridge UK; Cancer Research UK Cambridge Institute University of Cambridge Cambridge UK Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge Department of Oncology University of Cambridge, Addenbrooke's Hospital, Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre Cambridge UK 7Cambridge Research Institute, University of Cambridge, Cambridge, United Kingdom. From the Cancer Genomics Program, Department of Oncology, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, United Kingdom; and Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 13Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.; 14Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom. 7Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way; 4Cambridge Experimental Cancer Medicine Centre, Cambridge; 5Warwick Clinical Trials Unit, University of Warwick; and 6Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom; Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way; 4Cambridge Experimental Cancer Medicine Centre, Cambridge; 5Warwick Clinical Trials Unit, University of Warwick; and 6Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom; Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way; 4Cambridge Experimental Cancer Medicine Centre, Cambridge; 5Warwick Clinical Trials Unit, University of Warwick; and 6Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, United Kingdom CRUK Cambridge Institute, University of Cambridge, Cambridge, UK From the Department of Public Health and Primary Care and the Department of Oncology, University of Cambridge; Cambridge Research Institute; and Eastern Cancer Registration and Information Centre, Unit C, Cambridge, United Kingdom 6Cambridge Cancer Centre, Cambridge; Cancer Genomics Program, Department of Oncology 1 1 University of Cambridge, Hutchison-MRC Research Centre, Hills Road, Cambridge CB2 2XZ, UK 1] Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK [3] Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK. 10Cancer Research UK Cambridge Institute, Cambridge Cancer Centre, University of Cambridge, Cambridge, United Kingdom. Departments of Pathology and Biochemistry, University of Hong Kong, Hong Kong; Leukaemia Research Fund Centre, London SW3 6JB, United Kingdom; and Key Laboratory of Human Genome Research and Shanghai Institute of Haematology, and Xin-Hua Hospital, Shanghai Second Medical University, Shanghai 200025, China Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, United Kingdom; Department of Oncology, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, United Kingdom Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom;; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom;; Cambridge Breast Cancer Research Unit, Addenbrooke’s Hospital, Cambridge University Hospital National Health Service Foundation Trust, Cambridge CB2 0QQ, United Kingdom;; Department of Oncology, University of Cambridge, Cambridge CB2 0QQ, United Kingdom; Department of Oncology and Cancer Research UK Cambridge Institute and Department of Oncology Li Ka Shing Centre University of Cambridge Cambridge UK 11Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge, United Kingdom. Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge CB2 0QQ, United Kingdom;,; Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge; and 4Experimental Cancer Medicine Centre, Cancer Research UK, London, United Kingdom; Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge; and 4Experimental Cancer Medicine Centre, Cancer Research UK, London, United Kingdom; Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge; and 4Experimental Cancer Medicine Centre, Cancer Research UK, London, United Kingdom; Authors' Affiliations: 1Department of Oncology and Strangeways Research Laboratory, University of Cambridge; 2Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals; 3Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge; and 4Experimental Cancer Medicine Centre, Cancer Research UK, London, United Kingdom 5Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Center, Cambridge, United Kingdom.; 7Department of Oncology, Cambridge Breast Cancer Research Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; 8Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, England. 5Cancer Research UK, Cambridge Institute;; 6Cambridge Experimental Cancer Medicine Centre;; 7Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre;; 8Department of Oncology, University of Cambridge, Cambridge, United Kingdom; Cancer Research UK, Cambridge Institute, University of Cambridge Cambridge United Kingdom; Department of Oncology University of Cambridge Cambridge United Kingdom Cambridge Experimental Cancer Medicine Centre, Cambridge, UK,; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK,; Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK, Cancer Research UK Cambridge Research Institute Li Ka Shing Centre Cambridge UK Cancer Research UK Cambridge Institute, and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cancer Research UK Cancer Centre, Cambridge Biomedical Campus, Cambridge CB2 2QQ, UK Cancer Research UK, Cambridge Institute, Cambridge, United Kingdom; Department of Oncology, University of Cambridge, Cambridge, United Kingdom. University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. Cancer Research UK, Cambridge Institute, Cambridge, United Kingdom. Cancer Research UK Cambridge Institute, University of Cambridge Cambridge UK 11Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, England. 1Cancer Genomics Program, Department of Oncology, Hutchison-Medical Research Council Research Centre, University of Cambridge; 3Department of Oncology, Hutchinson/Medical Research Council Research Centre, University of Cambridge, Cambridge, United Kingdom Department of Oncology; University of Cambridge and Cancer Research UK, Cambridge Research Institute; UK Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge UK; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge UK; NIHR Cambridge Biomedical Research Centre, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge, UK. Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology and Breast Cancer Programme, CRUK Cambridge Centre, Cambridge University Hospitals NHS and University of Cambridge, Cambridge CB2 2QQ, UK. Department of Oncology Cancer Research UK Cambridge Institute University of Cambridge Cambridge UK Department of Oncology and Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge CB2 0RE, UK. Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom Oncology, and Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. Electronic address: [email protected]. |
Incoming Links
Showing number of triples: 1 to 508 of 508.